tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PGEN Stock Latest News

Precigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer
Company AnnouncementsPrecigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer
5d ago
PGEN
Precigen presents long-term data demonstrating durable responses to PAPZIMEOS
PremiumThe Fly
Precigen presents long-term data demonstrating durable responses to PAPZIMEOS
19d ago
PGEN
Precigen Converts Preferred Stock to Common Shares
PremiumCompany Announcements
Precigen Converts Preferred Stock to Common Shares
1M ago
8K
PGEN
Precigen Secures $125M Loan for PAPZIMEOS Expansion
PremiumCompany Announcements
Precigen Secures $125M Loan for PAPZIMEOS Expansion
2M ago
8K
PGEN
Precigen files to sell 143.81M shares of common stock for holders
PremiumThe Fly
Precigen files to sell 143.81M shares of common stock for holders
2M ago
PGEN
Buy Rating for Precigen: Strong Market Potential and Strategic Positioning of Papzimeos
PremiumRatingsBuy Rating for Precigen: Strong Market Potential and Strategic Positioning of Papzimeos
2M ago
PGEN
Precigen price target raised to $8 from $6 at Citizens JMP
Premium
The Fly
Precigen price target raised to $8 from $6 at Citizens JMP
2M ago
PGEN
Precigen Enters Commercial Supply Agreement with Catalent
Premium
Company Announcements
Precigen Enters Commercial Supply Agreement with Catalent
2M ago
8K
PGEN
Unusually active option classes on open August 18th
PremiumThe Fly
Unusually active option classes on open August 18th
3M ago
AG
IQ
Precigen’s PAPZIMEOS Receives FDA Approval for RRP
PremiumCompany Announcements
Precigen’s PAPZIMEOS Receives FDA Approval for RRP
3M ago
8K
PGEN
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
3M ago
DE
AMD
Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy
PremiumMarket News
Precigen Stock (PGEN) Roars Over 60% Higher on FDA Green Light for Papzimeos Therapy
3M ago
PGEN
Berkshire takes stake in UnitedHealth, Sandisk reports Q4 beat; Morning Buzz
PremiumThe FlyBerkshire takes stake in UnitedHealth, Sandisk reports Q4 beat; Morning Buzz
3M ago
GS
NU
Morning Movers: Precigen surges following full FDA approval of Papzimeos
Premium
The Fly
Morning Movers: Precigen surges following full FDA approval of Papzimeos
3M ago
DHI
FLO
Video: UnitedHealth jumps after Berkshire buy, Target slips after downgrade
Premium
The Fly
Video: UnitedHealth jumps after Berkshire buy, Target slips after downgrade
3M ago
TGT
UNH
Precigen price target raised to $8.50 from $6 at H.C. Wainwright
PremiumThe Fly
Precigen price target raised to $8.50 from $6 at H.C. Wainwright
3M ago
PGEN
Precigen announces FDA approval of Papzimeos for RRP treatment
PremiumThe Fly
Precigen announces FDA approval of Papzimeos for RRP treatment
3M ago
PGEN
Precigen upgraded to Neutral from Underweight at JPMorgan
PremiumThe Fly
Precigen upgraded to Neutral from Underweight at JPMorgan
3M ago
PGEN
Precigen jumps 32% to $2.44 after FDA approval of Papzimeos
PremiumThe Fly
Precigen jumps 32% to $2.44 after FDA approval of Papzimeos
3M ago
PGEN
FDA approves Precigen immunotherapy for respiratory papillomatosis
PremiumThe FlyFDA approves Precigen immunotherapy for respiratory papillomatosis
3M ago
PGEN
Precigen trading halted, news pending
Premium
The Fly
Precigen trading halted, news pending
3M ago
PGEN
Precigen’s Transformative Potential: Buy Rating Backed by Imminent FDA Decision and Strong Financial Outlook
Premium
Ratings
Precigen’s Transformative Potential: Buy Rating Backed by Imminent FDA Decision and Strong Financial Outlook
3M ago
PGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >